Japan's CBD market defies the conventional wisdom that regulatory tightening necessarily shrinks markets. The December 2024 Cannabis Control Act revision — which introduced mandatory THC residue limits and accelerated the CBN designation process — has if anything accelerated market consolidation around compliant brands. The opportunity for internationally sourced CBD products has never been more structured or, for those who enter correctly, more defensible.
Market Size and Growth
The Japanese CBD market was estimated at approximately ¥36 billion (approximately USD 240 million) in FY2025 by Yano Research Institute — modest growth over the ¥33 billion FY2024 figure despite significant channel disruption from enforcement actions. The resilience reflects the depth of Japanese consumer interest in CBD wellness products and the relatively low penetration of compliant products in the overall wellness market.
For context: Japan's dietary supplement market is approximately ¥900 billion annually. CBD products represent approximately 4% of that figure. Given CBD's profile in comparable markets (South Korea, Australia, UK) where regulatory clarity has existed for longer, a 10% share within 5 years is not an unreasonable scenario — a ¥90 billion market.
Channel Performance
E-Commerce (EC)
The dominant channel, accounting for an estimated 65% of CBD product sales in Japan. Amazon Japan, Rakuten Ichiba, and Yahoo! Shopping carry CBD products from domestic importers. Direct-to-consumer branded websites are increasingly important for premium positioning. The channel advantages: lower compliance scrutiny than brick-and-mortar, direct consumer relationship, strong review infrastructure that rewards product quality.
Natural & Specialty Retail
Growing channel, estimated 20% of sales. Natural food stores (Kaldi, Natural House, Bio c' Bon), yoga and wellness studios, and specialty supplement retailers. Buyer requirements have increased significantly following the December 2024 changes — all of the major chains now require Japan-accredited lab CoA and MHLW import notification confirmation before listing new products.
Drugstore & Mass Retail
Emerging channel, currently approximately 10% of sales but showing strong growth. The compliance bar is highest in this channel — major chains now require supplier compliance documentation equivalent to pharmaceutical product standards. For brands that can meet this standard, the scale opportunity is significant: Japan has approximately 60,000 drugstore locations.
Hospitality & Wellness
Hotels, spas, and wellness facilities are an early-stage but high-margin channel. CBD-infused amenities, spa treatments, and in-room wellness products are increasingly offered by properties targeting international guests. This channel requires compliance documentation tailored to cosmetic or quasi-drug regulation rather than food supplement regulation.
Consumer Profile
The core Japanese CBD consumer is health-conscious, between 30 and 50 years old, with above-average discretionary income, and typically introduced to CBD through online research or recommendation from a trusted source. Key use cases in order of prevalence: stress and anxiety relief, sleep support, general wellness, exercise recovery, and pain management.
Japanese consumers are distinctive in their sensitivity to compliance and brand trust. In consumer surveys, "confirmed legal in Japan" and "made by a Japanese company or imported by a Japanese specialist" rank among the top purchase drivers — above price and ahead of cannabinoid concentration claims. This is a market where compliance is a marketing asset, not merely a legal obligation.
The Brands Winning
The brands showing strongest performance in Japan's current market share several characteristics:
- Full compliance documentation: Japan-accredited CoA, MHLW import notification, clear labeling. These are presented as brand assets, not hidden in regulatory filings.
- Isolate-forward formulations: The compliance simplicity of isolate is a marketing advantage in Japan's current environment. Brands positioning on purity rather than complexity are outperforming.
- Premium pricing: Japan's CBD market is a premium market. Products priced at ¥5,000–¥15,000 per unit significantly outperform lower-priced alternatives on a per-unit margin basis. Japanese consumers correlate price with quality and compliance.
- Japanese-language content: While many CBD purchasers in Japan read English product descriptions, the brands with Japanese-language website content, labeling, and customer service have meaningfully higher conversion rates and return purchase rates.
Where the Opportunity Is Now
Three opportunity areas stand out for international brands evaluating Japan in 2026:
CBG as CBN Replacement
The ¥10 billion CBN market is actively displaced. The brand that owns Japan's CBG category in 2026 will have a significant first-mover advantage. See our dedicated analysis of the CBG opportunity.
Water-Soluble Compliance Gap
Most water-soluble CBD products that were imported before December 2024 do not comply with Japan's 0.1 ppm THC standard for aqueous products. The channel is underserved by compliant supply. A water-soluble CBD isolate formulation with proper Japan-accredited testing has a largely open distribution channel.
Premium Topicals
CBD topicals and cosmetics operate under a different — and somewhat more accessible — regulatory pathway than ingestible products. Japan's skincare market is one of the most developed globally. Premium CBD skincare from credible international brands remains significantly underpenetrated.